Ketim Technologies Advances to Round 3 of the Australian Technologies Competition

Brisbane, Australia – September 17, 2025 – Ketim Technologies, a leader in biomarker-driven innovations for women’s mental health, is proud to announce that the company advanced to Round 3 of the Australian Technologies Competition (ATC).

Out of 229 entries – the largest applicant pool in the competition’s 15-year history – Ketim Technologies secured a place among the top 37 finalists, competing in the Female-Led Startup category.

The ATC is one of Australia’s most prestigious national competitions, showcasing high-potential technology companies driving commercial success while creating positive economic, societal, and environmental impact.

“Being named a finalist among such a strong field of innovators is an incredible honour,” said Dr. Clarissa Yates, Ph.D., Founder and CEO of Ketim Technologies. “This recognition highlights both the strength of our mission – to deliver the world’s first protein blood test for predicting postpartum depression – and the growing importance of women-led innovation in Australia’s tech sector.”

Ketim Technologies congratulates all fellow finalists advancing in the competition.

For media inquiries, please contact:
Dr. Clarissa Yates
CEO, Ketim Technologies
clarissa.yates@ketim.com.au